FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1105-1107 April 10, 1997 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Oelkers, W. PubMed Citation

To the Editor: The concise review of adrenal insufficiency by Dr. Oelkers (Oct. 17 issue)¹ was excellent, but the corticotropin stimulation test is even less valuable than he suggests, and the incidence of clinically significant secondary adrenal insufficiency due to long-term glucocorticoid therapy is much lower than generally believed.^2,3,4,5 What does Dr. Oelkers recommend for patients receiving exogenous glucocorticoids? My data suggest that the adrenal function of such patients need not be tested except when there are clear-cut clinical indications, since in such patients the physiologic value of the biochemical tests is poor and clinical adrenal insufficiency is rare.

Jonathan . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Zackheim, H. S., Kashani-Sabet, M., Amin, S. (1998). Topical Corticosteroids for Mycosis Fungoides: Experience in 79 Patients. Arch Dermatol 134: 949-954 [Abstract] [Full Text]